EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $377,000 | -95.7% | 15,309 | -97.8% | 0.00% | -100.0% |
| Q1 2019 | $8,799,000 | -23.9% | 710,156 | -62.2% | 0.01% | -30.8% |
| Q4 2018 | $11,562,000 | -50.4% | 1,876,995 | -14.7% | 0.01% | -38.1% |
| Q3 2018 | $23,331,000 | -21.2% | 2,201,037 | +0.7% | 0.02% | -27.6% |
| Q2 2018 | $29,604,000 | -22.4% | 2,184,788 | +1.7% | 0.03% | -23.7% |
| Q1 2018 | $38,127,000 | +62.0% | 2,148,026 | +14.5% | 0.04% | +65.2% |
| Q4 2017 | $23,538,000 | -33.8% | 1,875,528 | +0.4% | 0.02% | -36.1% |
| Q3 2017 | $35,579,000 | +25.5% | 1,867,661 | -0.5% | 0.04% | +20.0% |
| Q2 2017 | $28,345,000 | -14.5% | 1,877,135 | -2.9% | 0.03% | -16.7% |
| Q1 2017 | $33,165,000 | +41.7% | 1,933,804 | 0.0% | 0.04% | +38.5% |
| Q4 2016 | $23,399,000 | +35.9% | 1,933,804 | +10.5% | 0.03% | +36.8% |
| Q3 2016 | $17,217,000 | -5.5% | 1,749,735 | -1.6% | 0.02% | -5.0% |
| Q2 2016 | $18,214,000 | -14.9% | 1,778,675 | +0.7% | 0.02% | -9.1% |
| Q1 2016 | $21,402,000 | +49.5% | 1,765,812 | +97.5% | 0.02% | +57.1% |
| Q4 2015 | $14,320,000 | +339.0% | 893,913 | +252.4% | 0.01% | +366.7% |
| Q3 2015 | $3,262,000 | -46.1% | 253,668 | +0.6% | 0.00% | -50.0% |
| Q2 2015 | $6,051,000 | +28.8% | 252,117 | +0.8% | 0.01% | +50.0% |
| Q1 2015 | $4,698,000 | – | 250,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |